In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

As the nation cautiously marks a two-year decline in overdose deaths, there are new warnings about emerging threats "even ...

President Donald Trump held a press conference Thursday announcing the launch of his new prescription drug discount service, ...

U.S agencies and Indian authorities are working together to stop fentanyl before it enters the American market.

The combination of GENEROUS for Medicaid, Globe for Medicare Part B and Guard for Medicare Part D will heavily impact the US drug market. President Trump’s rhetoric has been that other countries ...

On Super Bowl Sunday, the drug industry is trotting out lounging football stars, a shouting DJ Khaled, and the soothing tones ...

Broderick Omar Hopkins, a 47-year-old teacher in Athens ISD was arrested earlier this week and booked into the Henderson ...

Generic medications are not the same as brand medications. Small differences in ingredients that are permitted by the FDA may affect efficacy.

A Delhi High Court verdict on January 12 may have cleared the way for a significantly cheaper version of a blockbuster cancer therapy drug in India. The drug, Nivolumab, is effective against a range ...

Purpose: This study aims to investigate the risk of drug-induced cataract and examine its epidemiological patterns using real-world data. Methods: Data from the FDA Adverse Event Reporting System ...

Lev Facher covers the U.S. addiction and overdose crisis. The significant, recent decline in U.S. drug overdose deaths was driven in large part by a sudden shift in North America’s illicit drug supply ...

For more than 50 years, marijuana has been classified as a Schedule I drug, alongside drugs considered to have no accepted medical use, thanks to then-President Richard Nixon’s so-called War on Drugs.